Nature's Sunshine Products Inc (NATR): Depreciation & Amortization
$13.84M
Year ended 2025-12-31
$13.37M
Trailing 12 months to 2026-06-30
+7.9%
3-year compound annual growth
+5.2%
5-year compound annual growth
+11.8%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.84M | -2.6% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $14.22M | +20.3% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | $11.82M | +7.2% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $11.03M | -1.2% | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | $11.16M | +3.9% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $10.74M | +1.4% | 2022-03-08, From 2020-01-01 |
| 2019-12-31 | $10.60M | +8.1% | 2021-03-10, From 2019-01-01 |
| 2018-12-31 | $9.81M | +13.6% | 2020-03-11, From 2018-01-01 |
| 2017-12-31 | $8.63M | +79.6% | 2019-03-08, From 2017-01-01 |
| 2016-12-31 | $4.81M | +6.3% | 2019-03-08, From 2016-01-01 |
| 2015-12-31 | $4.53M | +2.6% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | $4.41M | -1.3% | 2017-03-14, From 2014-01-01 |
| 2013-12-31 | $4.47M | +9.5% | 2016-03-14, From 2013-01-01 |
| 2012-12-31 | $4.08M | -6.5% | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | $4.36M | +2.5% | 2014-03-17, From 2011-01-01 |
| 2010-12-31 | $4.25M | -5.5% | 2013-03-07, From 2010-01-01 |
| 2009-12-31 | $4.50M | n/a | 2012-03-05, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $13.84M | -2.6% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $60.74M | +39.5% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $5.43M | -10.6% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $15.01M | +26.6% |
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $24.24M | +2.6% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $13.31M | +7.8% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $15.27M | +12.1% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $3.06M | +48.3% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $91.63M | -6.7% |
Compare NATR, TVTX, BBIO, ZLAB side by side · Screen every company in Pharmaceutical Preparations ↗